BACKGROUND: Dysgerminoma is an uncommon malignant tumor arising from the germ cells of the ovary. Its association with pregnancy is extremely rare; the incidence is about 0.2-1 per 100,000 pregnancies. Because of its infrequency, there are few recommendations regarding its management in pregnancy; therefore, it is important to discuss and summarize the treatment strategy. CASE: We presented a case of a 23-year-old pregnant woman with a large dysgerminoma originated from the right ovary, which had the unusual coincidence of being associated with an abdominal desmoid tumor simultaneously. We did not find any similar cases published in the PubMed database after 1947. A cesarean section was performed at 34 + 6 weeks gestation secondary to her abdominal pain worsening. The patient delivered a healthy boy and had fertility-preserving surgery, followed by 6 cycles of chemotherapy. This case is compared with 21 other reported cases of pure ovarian dysgerminoma in the literature to evaluate the clinical characteristics, feto-maternal compromise, treatment, long-term survival, and fertility outcome. CONCLUSION: The treatment strategy in women with ovarian dysgerminoma should be discussed and structured on an individual basis. If pregnancy is desired, surgical intervention undertaken in the second trimester seems to be the first choice. When chemotherapy is indicated, unless delivery can be accomplished within a few weeks of diagnosis, it should not necessarily be delayed until after delivery. Good reproductive function and high survival rate can be achieved in patients treated with conservative surgery and adjuvant chemotherapy.
BACKGROUND:Dysgerminoma is an uncommon malignant tumor arising from the germ cells of the ovary. Its association with pregnancy is extremely rare; the incidence is about 0.2-1 per 100,000 pregnancies. Because of its infrequency, there are few recommendations regarding its management in pregnancy; therefore, it is important to discuss and summarize the treatment strategy. CASE: We presented a case of a 23-year-old pregnant woman with a large dysgerminoma originated from the right ovary, which had the unusual coincidence of being associated with an abdominal desmoid tumor simultaneously. We did not find any similar cases published in the PubMed database after 1947. A cesarean section was performed at 34 + 6 weeks gestation secondary to her abdominal pain worsening. The patient delivered a healthy boy and had fertility-preserving surgery, followed by 6 cycles of chemotherapy. This case is compared with 21 other reported cases of pure ovarian dysgerminoma in the literature to evaluate the clinical characteristics, feto-maternal compromise, treatment, long-term survival, and fertility outcome. CONCLUSION: The treatment strategy in women with ovarian dysgerminoma should be discussed and structured on an individual basis. If pregnancy is desired, surgical intervention undertaken in the second trimester seems to be the first choice. When chemotherapy is indicated, unless delivery can be accomplished within a few weeks of diagnosis, it should not necessarily be delayed until after delivery. Good reproductive function and high survival rate can be achieved in patients treated with conservative surgery and adjuvant chemotherapy.
Authors: G Mangili; C Sigismondi; D Lorusso; G Cormio; P Scollo; R Viganò; T Gamucci; M Candiani; S Pignata Journal: Gynecol Oncol Date: 2011-01-28 Impact factor: 5.482
Authors: Frédéric Amant; Michael J Halaska; Monica Fumagalli; Karina Dahl Steffensen; Christianne Lok; Kristel Van Calsteren; Sileny N Han; Olivier Mir; Robert Fruscio; Cathérine Uzan; Cynthia Maxwell; Jana Dekrem; Goedele Strauven; Mina Mhallem Gziri; Vesna Kesic; Paul Berveiller; Frank van den Heuvel; Petronella B Ottevanger; Ignace Vergote; Michael Lishner; Philippe Morice; Irena Nulman Journal: Int J Gynecol Cancer Date: 2014-03 Impact factor: 3.437
Authors: Matteo Lambertini; Nermine S Kamal; Fedro A Peccatori; Lucia Del Mastro; Hatem A Azim Journal: Expert Opin Drug Saf Date: 2015-07-03 Impact factor: 4.250
Authors: S Guerriero; A C Testa; D Timmerman; C Van Holsbeke; S Ajossa; D Fischerova; D Franchi; F P G Leone; E Domali; J L Alcazar; G Parodo; F Mascilini; B Virgilio; V N Demidov; J Lipatenkova; L Valentin Journal: Ultrasound Obstet Gynecol Date: 2011-04-05 Impact factor: 7.299